Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Drug Resistance

Free Subscription Articles published in Infect Control Hosp Epidemiol Retrieve available abstracts of 38 articles: HTML format

Single Articles

September 2025
1. WANG M, Shi Q, Sun W, Lin J, et al
   Epidemiology of device-associated healthcare-associated infections and carbapenem-resistant Enterobacteriaceae in intensive care units: a 7-year multicenter surveillance in Shanghai, China.
   Infect Control Hosp Epidemiol. 2025 Sep 15:1-7. doi: 10.1017/ice.2025.10292.
   PubMed     Abstract available
   
   
   
2. MEMIC S, Cadnum JL, Donskey CJ
   A ceiling-mounted far-ultraviolet-C light technology reduces methicillin-resistant Staphylococcus aureus contamination on surfaces in a simulated operating room.
   Infect Control Hosp Epidemiol. 2025 Sep 10:1-2. doi: 10.1017/ice.2025.10231.
   PubMed    
   
   
   
3. SILVA A, Bartoszko JJ, Cayen J, Choi KB, et al
   An interrupted time-series analysis assessing the association of the COVID-19 pandemic on healthcare-associated infections and antimicrobial-resistant organisms in Canadian acute care hospitals, 2018-2022.
   Infect Control Hosp Epidemiol. 2025 Sep 10:1-5. doi: 10.1017/ice.2025.10247.
   PubMed    
   
   
   
4. MITCHELL R, Lee D, Bartoszko J, Lybeck C, et al
   Trends in healthcare-associated infections and antimicrobial-resistant organisms among adults in Canadian acute care hospitals: findings from four point prevalence surveys, 2002 to 2024.
   Infect Control Hosp Epidemiol. 2025 Sep 10:1-8. doi: 10.1017/ice.2025.10259.
   PubMed     Abstract available
   
   
   August 2025
5. O'HARA LM, Newman M, Lydecker AD, Robinson GL, et al
   Enhanced barrier precautions to prevent transmission of Staphylococcus aureus and Carbapenem-resistant organisms in nursing home chronic ventilator units.
   Infect Control Hosp Epidemiol. 2025 Aug 22:1-8. doi: 10.1017/ice.2025.10237.
   PubMed     Abstract available
   
   
   
6. BRENNAN B, McNamara S, McCullor K, Soehnlen M, et al
   Investigation and laboratory characterization of the fifteenth U.S. case of vancomycin-resistant Staphylococcus aureus - Michigan, 2021.
   Infect Control Hosp Epidemiol. 2025 Aug 11:1-2. doi: 10.1017/ice.2025.10225.
   PubMed    
   
   
   July 2025
7. CHOU A, Hauser RG, Bastian LA, Brandt CA, et al
   Extracting antibiotic susceptibility from free-text microbiology reports using natural language processing.
   Infect Control Hosp Epidemiol. 2025 Jul 31:1-3. doi: 10.1017/ice.2025.10210.
   PubMed     Abstract available
   
   
   June 2025
8. SCHRADER SM, Baker MA, Rhee C, Klompas M, et al
   Whole-genome sequencing surveillance of vancomycin-resistant Enterococcus faecium (VRE) detects hospital outbreaks and identifies the postanesthesia care unit as a transmission locus.
   Infect Control Hosp Epidemiol. 2025 Jun 3:1-8. doi: 10.1017/ice.2025.
   PubMed     Abstract available
   
   
   May 2025
9. O'HARA LM, Calfee DP, Snyder GM, Martin EM, et al
   A discrete choice experiment to evaluate healthcare personnel preferences regarding risk-tailored policies for contact precautions for patients with methicillin-resistant Staphylococcus aureus.
   Infect Control Hosp Epidemiol. 2025 May 16:1-6. doi: 10.1017/ice.2025.
   PubMed     Abstract available
   
   
   
10. ROGOZIN E, Maree H, Masarwi M, Hasona R, et al
    Usage of oral vancomycin for acute Clostridioides difficile infection (CDI) resulting in later acquisitions of vancomycin-resistant enterococci (VRE).
    Infect Control Hosp Epidemiol. 2025 May 16:1-7. doi: 10.1017/ice.2025.
    PubMed     Abstract available
    
    
    April 2025
11. BOHJANEN S, Goldstick C, Hordinsky M
    Testing for methicillin-resistant Staphylococcus aureus in the anterior nares for antibiotic de-escalation in patients presenting with acute skin and soft tissue infections: systematic review and meta-analysis.
    Infect Control Hosp Epidemiol. 2025 Apr 16:1-5. doi: 10.1017/ice.2025.
    PubMed     Abstract available
    
    
    March 2025
12. JONES S, Stanton R, D'Angeli M, Brezak A, et al
    Community-associated New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales: multiple states, from September 2021 through September 2022.
    Infect Control Hosp Epidemiol. 2025 Mar 24:1-4. doi: 10.1017/ice.2025.
    PubMed     Abstract available
    
    
    February 2025
13. PRAKASH-ASRANI R, Bower C, Robichaux C, Chan B, et al
    Identifying patients at high risk for carbapenem-resistant Enterobacterales (CRE) carriage on admission to acute care hospitals: validating and expanding on a public health model.
    Infect Control Hosp Epidemiol. 2025 Feb 14:1-6. doi: 10.1017/ice.2025.
    PubMed     Abstract available
    
    
    January 2025
14. SANTOS CAQ, Won SY, Dwyer R, Perez C, et al
    Benchmarking antimicrobial use to antimicrobial resistance: a comparative study of two hospitals using current National Healthcare Safety Network (NHSN) metrics.
    Infect Control Hosp Epidemiol. 2025 Jan 27:1-8. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    December 2024
15. WU CT, Shropshire WC, Bhatti MM, Cantu S, et al
    Rapid whole genome characterization of antimicrobial-resistant pathogens using long-read sequencing to identify potential healthcare transmission.
    Infect Control Hosp Epidemiol. 2024 Dec 27:1-7. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    
16. KIM T, Moehring RW, Turner NA, Ashley ED, et al
    Long-term trends in the incidence of hospital-acquired carbapenem-resistant Enterobacterales and antimicrobial utilization in a network of community hospitals in the Southeastern United States from 2013 to 2023.
    Infect Control Hosp Epidemiol. 2024 Dec 3:1-7. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    November 2024
17. LIM LL, Lim KWE, Malloy MJ, Bull A, et al
    Antimicrobial-resistant central line-associated bloodstream infections in adult intensive care units: findings from an Australian surveillance network, 2011-2022.
    Infect Control Hosp Epidemiol. 2024 Nov 7:1-7. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    October 2024
18. KIRTZ EM, Chan A, McClanahan K, Octaria R, et al
    Leveraging multi-database linkages to assess racial and ethnic disparities among Carbapenem-resistant Enterobacterales cases in Tennessee, 2015-2019.
    Infect Control Hosp Epidemiol. 2024 Oct 2:1-7. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    August 2024
19. LYON E, Goldman J, Lee B, Campbell M, et al
    Repeat tracheal aspirate cultures in pediatric intensive care patients: Frequency, resistance, and antimicrobial use.
    Infect Control Hosp Epidemiol. 2024;45:936-942.
    PubMed     Abstract available
    
    
    July 2024
20. CINCOTTA SE, Walters MS, Ham DC, Octaria R, et al
    Regional impact of multidrug-resistant organism prevention bundles implemented by facility type: A modeling study.
    Infect Control Hosp Epidemiol. 2024;45:856-863.
    PubMed     Abstract available
    
    
    May 2024
21. VAIVOOTHPINYO S, Sathitakorn O, Jantarathaneewat K, Weber DJ, et al
    The impact of environmental cleaning protocol featuring PX-UV in reducing the incidence of multidrug-resistant gram-negative healthcare-associated infection and colonization in intensive care units in Thailand.
    Infect Control Hosp Epidemiol. 2024;45:684-687.
    PubMed     Abstract available
    
    
    April 2024
22. O'HARA LM, Harris AD, Calfee DP, Snyder GM, et al
    Healthcare personnel opinions regarding the feasibility of a risk-tailored approach to contact precautions for methicillin-resistant Staphylococcus aureus in the acute care setting.
    Infect Control Hosp Epidemiol. 2024 Apr 22:1-3. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    
23. CALISKAN G, Eren H, Aslan F, Tezgec N, et al
    Surveillance of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli in perianal swab samples.
    Infect Control Hosp Epidemiol. 2024 Apr 12:1-4. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    March 2024
24. WANG L, Zeng C, Li X, Li Y, et al
    Mortality associated with carbapenem resistance in Klebsiella pneumoniae bloodstream infection: A propensity score-matched study.
    Infect Control Hosp Epidemiol. 2024 Mar 15:1-8. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    
25. ABIMANSOUR J, Martin JA, Petersen BT
    Implementation of multidrug-resistant bacterial testing to prioritize duodenoscope sterilization: Experience from a high-volume health system.
    Infect Control Hosp Epidemiol. 2024;45:397-399.
    PubMed    
    
    
    February 2024
26. CUI J, Heavey J, Lin L, Klein EY, et al
    Modeling relaxed policies for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions.
    Infect Control Hosp Epidemiol. 2024 Feb 26:1-6. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    
27. FONTANA L, Hakki M, Ozer EA, Laird A, et al
    The impact of an intervention to reduce dispersal from wastewater drain sites on carbapenem-resistant Pseudomonas aeruginosa colonization and bloodstream infection on a hematopoietic cell transplant and hematologic malignancy unit.
    Infect Control Hosp Epidemiol. 2024 Feb 22:1-9. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
28. HOWARD-ANDERSON JR, Gottlieb LB, Beekmann SE, Polgreen PM, et al
    Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.
    Infect Control Hosp Epidemiol. 2024 Feb 14:1-6. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    January 2024
29. KISS CR, Ryan S, Meyer J, Kotsanas D, et al
    Impact of change in vancomycin-resistant Enterococcus infection prevention policy.
    Infect Control Hosp Epidemiol. 2024 Jan 22:1-2. doi: 10.1017/ice.2023.
    PubMed    
    
    
    
30. WARREN BG, Smith BA, Barrett A, Graves AM, et al
    Identification of carbapenem-resistant organism (CRO) contamination of in-room sinks in intensive care units in a new hospital bed tower.
    Infect Control Hosp Epidemiol. 2024 Jan 19:1-8. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
31. ADEDIRAN TY, Robinson GL, Johnson JK, Liang Y, et al
    Factors associated with patient-to-healthcare personnel (HCP) and HCP-to-subsequent patient transmission of methicillin-resistant Staphylococcus aureus.
    Infect Control Hosp Epidemiol. 2024 Jan 18:1-7. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    December 2023
32. SIMON SJ, Sater M, Herriott I, Huntley M, et al
    Staphylococcus epidermidis joint isolates: Whole-genome sequencing demonstrates evidence of hospital transmission and common antimicrobial resistance.
    Infect Control Hosp Epidemiol. 2023 Dec 15:1-7. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
33. HUYNH DN, Shah PJ, Greenlee SB, Long SW, et al
    Evaluation of computerized clinical decision support system to reduce unnecessary nasal methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) testing.
    Infect Control Hosp Epidemiol. 2023 Dec 12:1-3. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    September 2023
34. BEN-DAVID D, Cohen Y, Levi G, Keren-Paz A, et al
    Contribution of active surveillance cultures to the control of hospital-acquired carbapenem-resistant Acinetobacter baumannii in an endemic hospital setting.
    Infect Control Hosp Epidemiol. 2023 Sep 20:1-8. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
35. PETTIT NN, Nguyen CT, Lew AK, Pisano J, et al
    Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for anti
    Infect Control Hosp Epidemiol. 2023 Sep 13:1-5. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    July 2023
36. ROTHBERG MB, Haessler S, Deshpande A, Yu PC, et al
    Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia.
    Infect Control Hosp Epidemiol. 2023;44:1143-1150.
    PubMed     Abstract available
    
    
    June 2023
37. FARTHING TS, Jolley A, Nickel KB, Hill C, et al
    Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients.
    Infect Control Hosp Epidemiol. 2023 Jun 29:1-6. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    December 2022
38. SCHWABER MJ, Temkin E, Lobl R, Schechner V, et al
    Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel.
    Infect Control Hosp Epidemiol. 2022 Dec 23:1-6. doi: 10.1017/ice.2022.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.